SCOPUS 정보 검색 플랫폼

Volumn 11, Issue 1, 2011, Pages 42-46

Controlled release & nanotechnologies: Recent advances & future opportunities

a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; APREPITANT; DEXMETHYLPHENIDATE; DURASOLV; FENOFIBRATE; MEGESTROL ACETATE; METHYLPHENIDATE; MORPHINE SULFATE; OLANZAPINE; ORASOLV; PACLITAXEL; PALIPERIDONE; RAPAMYCIN; SUSTENNA; UNCLASSIFIED DRUG;

ATTENTION DEFICIT DISORDER; CONTROLLED DRUG RELEASE; DRUG ABUSE; DRUG ADMINISTRATION ROUTE; DRUG APPROVAL; DRUG DELIVERY SYSTEM; DRUG MARKETING; DRUG SOLUBILITY; FOOD AND DRUG ADMINISTRATION; HUMAN; NANOTECHNOLOGY; ORAL DRUG DELIVERY; SCHIZOPHRENIA; SHORT SURVEY; TABLET FORMULATION;

EID: 79951548173 PISSN: 15372898 EISSN: 1944818X Source Type: Trade Journal
DOI: None Document Type: Short Survey

Times cited : (2)

References (17)

1
- 79951532632
- MedTRACK presentation made by
- MedTRACK presentation made by Sarah Terry, CRS Annual Meeting, Portland Oregon, July 2010.
- CRS Annual Meeting, Portland Oregon, July 2010
- Terry, S.¹

2
- 79951546695
- 2010 Report From New England Healthcare Institute.
- 2010 Report from New England Healthcare Institute

3
- 79951531502
- US Patent No. 6,110,494
- US Patent No. 6,110,494.

4
- 0031946793
- Butler A, et al. Pharm Tech. 1998;22(3):122-138.
- (1998) Pharm Tech , vol.22 , Issue.3 , pp. 122-138
- Butler, A.¹

5
- 78149346586
- Associated Press. Associated Press, March 12, Available at
- Associated Press. Scientists explore abuse resistant painkillers, Associated Press, March 12, 2007. Available at http://www.msnbc.msn.com/id/ 17581544/.
- (2007) Scientists Explore Abuse Resistant Painkillers

6
- 78149352753
- Press release posted December 11, Available at
- Pain Therapeutics Receives Complete Response Letter From FDA for REMOXY®. Press release posted December 11, 2008. Available at http://investor.paintrials.com/releasedetail.cfm?ReleaseID=354003
- (2008) Pain Therapeutics Receives Complete Response Letter from FDA for REMOXY®

7
- 78149290413
- Discussing Gastro-retentive drug delivery systems
- Dubin C. Discussing Gastro-retentive drug delivery systems. Drug Delivery Technology. 2007;7(6,):26-29.
- (2007) Drug Delivery Technology , vol.7 , Issue.6 , pp. 26-29
- Dubin, C.¹

8
- 85056960869
- CRC Press
- Touitou E, Barry BW. Enhancement in Drug Delivery. CRC Press. 2006:77-80.
- (2006) Enhancement in Drug Delivery , pp. 77-80
- Touitou, E.¹ Barry, B.W.²

9
- 22844436560
- Supercritical fluid technology for enhanced drug delivery
- DOI 10.1517/17425247.2.4.747
- Pathak P, Meziani MJ, Sun Y-P. Supercritical fluid technology for enhanced drug delivery. Expert Opin Drug Deliv. 2005;2:747-761. (Pubitemid 41038685)
- (2005) Expert Opinion on Drug Delivery , vol.2 , Issue.4 , pp. 747-761
- Pathak, P.¹ Meziani, M.J.² Sun, Y.-P.³

10
- 55349085112
- Forming nanoparticles via controlled crystallization
- Panagiotou T, Fisher RJ. Forming nanoparticles via controlled crystallization. Chemic Eng Progress. 2008:33-39.
- (2008) Chemic Eng Progress , pp. 33-39
- Panagiotou, T.¹ Fisher, R.J.²

11
- 0037312695
- Nanosizing: A formulation approach for poorly water-soluble compounds
- Merisko-Liversidge E, Liversidge GG, Cooper ER. Nanosizing: a formulation approach for poorly water-soluble compounds. Eur J Pharm Sci.2004;18:113-120.
- (2004) Eur J Pharm Sci , vol.18 , pp. 113-120
- Merisko-Liversidge, E.¹ Liversidge, G.G.² Cooper, E.R.³

12
- 0035937599
- Nanosuspensions as particulate drug formulations in therapy: Rationale for development and what we can expect for the future
- DOI 10.1016/S0169-409X(00)00118-6, PII S0169409X00001186
- Muller RH. Nanosuspensions as particulate drug formulations in therapy: rationale for development and what we can expect in the future. Adv Drug Del Rev. 2001;47:3-19. (Pubitemid 32209229)
- (2001) Advanced Drug Delivery Reviews , vol.47 , Issue.1 , pp. 3-19
- Muller, R.H.¹ Jacobs, C.² Kayser, O.³

13
- 4544383493
- Nanosuspensions in drug delivery
- DOI 10.1038/nrd1494
- Rabinow BE. Nanosuspensions in drug delivery. Nature Reviews: Drug Del. 2004;3:785-796. (Pubitemid 39242830)
- (2004) Nature Reviews Drug Discovery , vol.3 , Issue.9 , pp. 785-796
- Rabinow, B.E.¹

14
- 0033015283
- Novel injectable formulations of insoluble drugs
- Pace S, Pace GW, Parikh I, Mishra A. Novel injectable formulations of insoluble drugs. Pharm Tech. 1999;23:116-134. (Pubitemid 29135950)
- (1999) Pharmaceutical Technology , vol.23 , Issue.3 , pp. 116-134
- Pace, S.N.¹ Pace, G.W.² Parikh, I.³ Mishra, A.K.⁴

15
- 34548010315
- Production of stable drug nanospensions using microfluidics reaction technology
- 2007 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2007, Technical Proceedings
- Panagiotou T, Mesite S, Fisher R, Gruveman I. Production of stable nanosuspensions using mircofluidics reaction technology. Nanotech. 2007;4:246-249. (Pubitemid 47277321)
- (2007) 2007 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2007, Technical Proceedings , vol.4 , pp. 246-249
- Panagiotou, T.¹ Mesite, S.² Fisher, R.³ Gruverman, I.⁴

16
- 76849115260
- Nanotechnology for drug delivery: A validated technology?
- Bottomley K. Nanotechnology for drug delivery: a validated technology? Drug Deliv Report. 2006:20-21.
- (2006) Drug Deliv Report , pp. 20-21
- Bottomley, K.¹

17
- 79951523276
- January
- Business Insights. Nanotechnology in Healthcare. January 2010.
- (2010) Business Insights. Nanotechnology in Healthcare

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.